These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Search MEDLINE/PubMed


  • Title: Mycophenolate mofetil may serve as a steroid-sparing agent for sarcoidosis.
    Author: Kouba DJ, Mimouni D, Rencic A, Nousari HC.
    Journal: Br J Dermatol; 2003 Jan; 148(1):147-8. PubMed ID: 12534610.
    Abstract:
    Sarcoidosis is an inflammatory disease with potentially severe mucocutaneous manifestations. Mycophenolate mofetil (MMF) is an immunosuppressive drug extensively used in organ transplantation. Its use has been rapidly expanded into autoimmune and inflammatory diseases. We report the first successful and safe use of MMF in five patients with sarcoidosis.
    [Abstract] [Full Text] [Related] [New Search]